Alnylam completes follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Date completed: 2/14/12 Type: Follow-on Raised: $92.7 million Shares: 8.6 million Price: ...